What's new on the horizon for rheumatoid arthritis management.

• Tác giả: Andrew Bit Mansour, Karmtej S Cheema, Siba P Raychaudhuri
• Ngôn ngữ: eng
• Thông tin xuất bản: Netherlands : Best practice & research. Clinical rheumatology , 2025
• Bộ sưu tập: NCBI
• ID: 709876

Tóm tắt

Rheumatoid arthritis (RA) is a chronic multisystem common autoimmune disease. Joints and the whole musculoskeletal system bear the brunt of the disease. Proper adequate treatment at the early stage is the foremost necessity to protect the patients from long term disabilities and reduce patient systemic morbidities including atherosclerosis and coronary artery disease. New biologic and non-biologic antirheumatic drugs in the last two decades have brought new dimensions for treat to target strategy and array of novel therapies for RA are in the horizon. Here in this systematic review our objective is to provide an overview of current developments and potentially available therapeutic options for RA. Novel immune-based therapies has the potential to change the treatment for RA. We have discussed in detail about the new drugs for RA in the horizon and provided analyses of the future drugs in pipeline for the management of RA.